Market Place
Sourcing Support
Novo Nordisk A/S: Share Repurchase Programme
27 Apr 2026 //
GLOBENEWSWIRE
Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide
27 Apr 2026 //
FIERCE PHARMA
Lilly`s Obesity Pill Shows Modest Performance In Second Week
24 Apr 2026 //
REUTERS HEALTHCARE
MHRA Approves 48-Hour Controlled-Temp Storage for Wegovy
23 Apr 2026 //
PHARMIWEB
New Funding Paves Way for Better Diagnostics, Biosolutions
23 Apr 2026 //
GLOBENEWSWIRE
Novo`s Etavopivat Meets Both Endpoints in Sickle Cell Disease
20 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
20 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk weight-loss drug shows liver benefits in mouse study
16 Apr 2026 //
REUTERS
Wegovy-maker Novo Nordisk partners with OpenAI
16 Apr 2026 //
REUTERS
MHRA Approves Single-Dose Injection Device For Wegovy 7.2Mg
14 Apr 2026 //
PHARMIWEB
Pharma Gears Up For Q1 Earnings With Focus On Deals
14 Apr 2026 //
BIOSPACE
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
Novo Nordisk A/S: Share Repurchase Programme
13 Apr 2026 //
GLOBENEWSWIRE
Mounjaro Sales Decline Due To Semaglutide Generics` Rise
10 Apr 2026 //
ECONOMICTIMES
Novo`s GLP-1 Pioneer Retires; Obesity Leader Joins Boehringer
10 Apr 2026 //
ENDPOINTS NEWS
Novo Nordisk launches higher-dose Wegovy in the United States
10 Apr 2026 //
PRNEWSWIRE
Generic Drugmakers Rush As Novo Nordisk Loses Weight-Loss Drug
09 Apr 2026 //
ECONOMICTIMES
Novo`s Wegovy: First EU-Approved GLP-1 for 48-Week Use
09 Apr 2026 //
GLOBENEWSWIRE
After $2.1B Novo Deal, Vivtex Is Just Getting Started
08 Apr 2026 //
FIERCE BIOTECH
Novo Nordisk A/S: Share Repurchase Programme
07 Apr 2026 //
GLOBENEWSWIRE
UK Cost Watchdog Clears Novo`s Wegovy For Cardio Risk Reduction
01 Apr 2026 //
FIERCE PHARMA
In Deal Fraud Dispute With Novo, KBP Looks To Revive Heart Drug
01 Apr 2026 //
FIERCE BIOTECH
Novo Nordisk Slashes Ozempic, Wegovy Prices by Up to 48% in India
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk Cuts 400 Roles At Troubled Bloomington Site
31 Mar 2026 //
FIERCE PHARMA
Weight Watchers Introduces Competitive Self-Pay Wegovy Pricing
31 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Plans To Cut Price Of Ozempic As Generics Hit Market
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk A/S: Share Repurchase Programme
30 Mar 2026 //
GLOBENEWSWIRE
Novo`s long-acting insulin Awiqli wins FDA nod
28 Mar 2026 //
PR NEWSWIRE
Articles of Association for Novo Nordisk 2026
27 Mar 2026 //
GLOBENEWSWIRE
Resolutions from the Annual General Meeting of Novo Nordisk A/S
26 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Triple Agonist UBT251 Cuts HbA1c by 2.16% in Phase 2
25 Mar 2026 //
GLOBENEWSWIRE
Novo Faces Access Challenges Despite Strong Wegovy Launch
25 Mar 2026 //
BIOSPACE
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Weight Loss Drug Market Sees Surge From Pharma Companies
24 Mar 2026 //
ECONOMICTIMES
Lexicon, Novo Launch Oral LX9851 Phase 1 Obesity Trial
23 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S: Share Repurchase Programme
23 Mar 2026 //
GLOBENEWSWIRE
Novo To Track Generic Surge As Semaglutide Goes Off Patent
21 Mar 2026 //
ECONOMICTIMES
Novo To Track Generic Surge As Semaglutide Goes Off Patent
20 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
FDA Approves Wegovy HD to Maximize Weight Loss
20 Mar 2026 //
PR NEWSWIRE
Novo Nordisk A/S Launches Share Buyback Program
16 Mar 2026 //
GLOBENEWSWIRE
Patent Expirations Push Biopharma Industry Toward A Tougher 2026
13 Mar 2026 //
FIERCE PHARMA
Novo’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
13 Mar 2026 //
BIOSPACE
Novo Holdings Announces 2025 Annual Results
12 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
FDA Issues Form 483 to Novo Nordisk
10 Mar 2026 //
FDA
Novo Nordisk’s Receives FDA Warning Letter
10 Mar 2026 //
FDA
Novo Nordisk Boosts Semaglutide Over Eli Lilly In Market Share
09 Mar 2026 //
ECONOMICTIMES
Hims & Hers Announces Strategic Shift For US Weight Loss Business
09 Mar 2026 //
BUSSINESSWIRE
Novo Nordisk Ends GLP-1 Dispute With Hims & Hers
09 Mar 2026 //
BIOSPACE
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
Novo Nordisk Launches Share Repurchase Program
09 Mar 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad
04 Mar 2026 //
FIERCE PHARMA
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
Novo Charts $500M Ireland Upgrade To Produce Wegovy Pill
03 Mar 2026 //
FIERCE PHARMA
Novo Allocates $506M To Convert Irish Plant For Oral Wegovy
02 Mar 2026 //
BIOSPACE
Novo Nordisk Expands Athlone, Ireland Facility By Over 400M Euros
02 Mar 2026 //
GLOBENEWSWIRE
